I think the important thing we can derive from the presentation...

I think the important thing we can derive from the presentation is that it simply works! Now that we know we can produce a non-viral method of Omnicar, we can get to work on the efficacy and generate some preclinical data.

Do Thermofisher want to help us along through clinical trials? That would be a win win for both companies.

If Omnicar is truly going to be a platform technology that potentially has multiple collaborators, it is in TF’s best interest that we make steady progress.

Not to mention there are not very many companies pursuing Non-viral methods. The more data they can get into the world that it is a viable option, the more components they will sell!

I’m anticipating more announcements to follow in regards to the Prescient/Thermofisher collaboration future.